National Comprehensive Cancer Network



Educational Events & Programs

CONFERENCE DATES > Friday, September 30 – Saturday, October 1, 2016REGISTER >

CONFERENCE LOCATION > New York Marriott Marquis • New York, New York

Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.

This year's congress will kick off with Registration, Exhibits, and Refreshments on Friday, September 30th at 4:30 PM followed by educational sessions starting at 6:00 PM. The congress will end at 5:00 PM on Saturday, October 1st.

CO-CHAIRS:

Description: Ranjana H. Advani, MD

Ranjana H. Advani, MD
Stanford Cancer Institute

 

 

 

Description: Andrew D. Zelenetz, MD, PhD

Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center

 

 

 

AGENDA*

Friday, September 30, 2016

4:30 – 6:00 PM

Registration, Exhibits, and Refreshments

6:00 – 6:15 PM

Opening Remarks

6:15 – 6:40 PM

Myeloproliferative Neoplasms and Myelofibrosis: Evolving Management

6:45 – 7:10 PM

Does Generic Imatinib Change the Treatment Approach in CML?

7:15 – 7:40 PM

AML: Are We Finally Making Real Progress?

7:45 – 8:35 PM

Patient Case Studies and Panel Discussion
(Elderly AML, Slow Responding or Emerging Mutation CML, “Incidental” Identification of a JAK2 Mutant Clone)


Saturday, October 1, 2016

6:30 AM

Registration Desk Opens

7:00 – 8:15 AM

Exhibits and Breakfast

8:15 – 8:20 AM

Opening Remarks

8:20 – 9:10 AM

Patient Case Studies and Panel Discussion
(Nasal NK/T-cell, Adult T-cell Leukemia/Lymphoma (ATLL), Primary Cutaneous Gamma-delta T-cell Lymphoma)

9:15 – 9:40 AM

How I Treat Peripheral T-cell Lymphoma

9:45 – 10:10 AM

Supportive Care in the Management of T-cell Lymphomas

10:10 – 10:25 AM

Break and Exhibits

10:25 – 10:50 AM

Diffuse Large B-cell Lymphoma: Is Cell of Origin Necessary for Treatment Selection?

10:55 – 11:20 AM

Early-stage Classical Hodgkin Lymphoma (CHL): Can We Eliminate Radiation Therapy for Most Patients?

11:25 AM – 12:00 PM

Shared Decision Making at Key Points in the Management of Hematologic Malignancies

12:00 – 1:15 PM

Lunch and Exhibits

1:15 – 2:05 PM

Patient Case Studies and Panel Discussion
(Smoldering Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Multiple Myeloma with Renal Failure)

2:10 – 2:35 PM

Multiple Myeloma: Diagnosis and Primary Treatment

2:40 – 3:05 PM

How to Integrate the New Drugs into the Management of Multiple Myeloma

3:10 – 3:35 PM

Getting Patients through Therapy: Supportive Care in Multiple Myeloma

3:35 – 3:50 PM

Break and Exhibits

3:50 – 4:15 PM

ALL: New Options for Relapsed Disease

4:20 – 5:00 PM

Debate—Examining Controversies in the Front-line Management of CLL: Chemo-immunotherapy vs. Continuous TKI Therapy

5:00 PM

Closing Remarks

 

*This agenda is subject to change. Faculty will be updated as confirmed.

Last updated on July 6, 2016


INTENDED AUDIENCE

This congress is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.

ACCREDITATION INFORMATION

This congress is approved for AMA PRA Category 1 Credit™ and is also certified for nurses and pharmacists.

SUPPORTERS

This educational activity is supported by educational grants from MEI Pharma and Takeda Oncology.  
(As of July 12, 2016)

NCCN is currently seeking support for this activity. Organizations who are interested in supporting NCCN CE programs are encouraged to contact Deborah Moonan, Director, Continuing Education.

FEES

Early Bird Registration Fee Discounts expire Friday, August 19, 2016Learn more.

Registration fee discounts are available to NCCN Member Institution employees! 
As a benefit of membership, NCCN extends a registration fee discount to staff employed at NCCN Member Institutions. Complimentary registration is available for residents, fellows and junior faculty at NCCN Member Institutions. Learn more.

Complimentary Registration for Fellows
Fellows must provide a letter on institution letterhead from their Director stating that they are a Fellow in good standing. Fellows must register by Friday, September 16, 2016. Learn more.

ACCOMMODATIONS

NCCN has a limited number of rooms reserved for registered attendees for the nights of Friday, September 30th and Saturday, October 1st at a discounted rate of $305 per night. Please book your room by Thursday, September 8th to take advantage of this special rate. Early booking is strongly encouraged. Learn more.


Earn up to 8 credits online!

The NCCN 10th Annual Congress: Hematologic Malignancies™ took place October 16 – 17, 2015 in San Francisco, California. Recorded Presentations from this meeting are now available at education.nccn.org/hem2015.

Learn more about the NCCN Evidence Blocks™:


Exhibitor Information

Organizations who are interested in exhibiting at NCCN programs are encouraged to contact Jennifer Tredwell, Senior Director, Marketing.


Future Hematologic Malignancies Congress Dates:

  • NCCN 12th Annual Congress: Hematologic Malignancies™
    Friday, October 6, 2017 – Saturday, October 7, 2017
    Hilton San Francisco Union Square • San Francisco, California

Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.